[LGND] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -227.64%
YoY- -103.62%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 69,990 41,848 41,420 33,161 27,003 24,808 24,987 98.08%
PBT 3,370 -11,612 28,119 -30,415 -8,175 -19,871 -18,028 -
Tax -2,391 -4,911 6,033 -6,284 -810 -4,620 -3,609 -23.90%
NP 5,761 -6,701 22,086 -24,131 -7,365 -15,251 -14,419 -
Tax Rate 70.95% - -21.46% - - - - -
Total Cost 64,229 48,549 19,334 57,292 34,368 40,059 39,406 38.29%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 8.23 -16.01 53.32 -72.77 -27.27 -61.48 -57.71 -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS 0.36 -0.42 1.38 -1.46 -0.43 -0.81 -0.74 -
EPS Diluted 0.35 -0.42 1.32 -1.46 -0.43 -0.81 -0.74 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.